Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Reverse Splits

So I expect before the split the stock would have done equally as well given the fact earnings and stock earnings multiples drive stock price not splits.



Again, I have to disagree. As with PTSC, there were too many shares issued. Once reduced, then earnings and PE came into play to maintain an increasing price commensurate with those earnings. I respectfully suggest a read of SEC filings and historical price data before the split to understand the logic/success of MSTR and how it may compare with PTSC.





Be well

Share
New Message
Please login to post a reply